亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Direct Contact Blood Brain Barrier Triculture

总结
Researchers at Purdue University have developed a model that represents a more restrictive, accurate model of the BBB. This model is a direct contact, triculture model containing astrocytes, pericytes, and the brain microvessel endothelial cells (BMEC) configured in a physiologically similar manner to an in vivo BBB. This method allows for direct contact between the pericytes and the astrocytes and measures the transendothelial electrical resistance (TEER) as an indirect measure of cell tightness. Researchers monitor the TEER until they determine a window in which a triculture would be of utility for permeability studies. This model will offer superior selectivity for screening neuroactive or neurotoxicant agents in vitro and help in the rational selection of candidates for advancement into further clinical studies based on its physiological similarity to the in vivo BBB cellular configuration. This model may also be adopted to select compounds that have a lower potential of eliciting a neurotoxicant effect.
技术优势
More accurate model representing the BBB Allows materials to permeate through it Allows for direct contact between the astrocytes and pericytes
技术应用
Medical/Health Pharmaceuticals Research & Development Drug discovery
详细技术说明
Gregory KnippKnipp LabPurdue Industrial and Physical Pharmacy
*Abstract

*Background
Neurological disorders have been steadily increasing over the last several decades. While drug discovery and development efforts to mitigate these diseases have concurrently increased to meet the change in prevalence, clinical translation into marketed products have been hindered. One of the main difficulties in creating this translation is the lack of a model that can predict the ability of new chemical entities to permeate through the brain blood barrier (BBB). Current models suffer from leakiness of the in vitro cellular tight junctions and that leakiness leads researchers to overestimate the amount of drug permeation.
*IP Issue Date
None
*IP Type
Provisional
*Stage of Development
Prototype testing validated
*Web Links
Purdue Office of Technology CommercializationPurdue Innovation and EntrepreneurshipGregory KnippKnipp LabPurdue Industrial and Physical Pharmacy
国家
United States
申请号码
None
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备